查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
輸血診斷市場 - 增長、未來展望、競爭分析，2023-2031
市場調查報告書
商品編碼
1293826

輸血診斷市場 - 增長、未來展望、競爭分析，2023-2031

Blood Transfusion Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 112 Pages | 商品交期: 最快1-2個工作天內

價格

輸血診斷市場是醫療保健行業的重要組成部分，在確保安全高效的輸血實踐中發揮著關鍵作用。 預計 2023 年至 2031 年期間，該市場將以 7% 的複合年增長率增長。 該市場的推動因素包括對血液和血液製品的需求不斷增長、對輸血相關疾病的認識不斷提高以及對準確有效的診斷方法的需求。 市場收入穩步增長，預計將繼續呈上升趨勢。 市場收入受到手術、創傷病例以及慢性病導致的輸血數量增加等因素的影響。 此外，血液相關疾病患病率的上升和老年人口的增加也增加了對輸血診斷的需求。 技術進步已經開發出創新的診斷方法，可以提供準確、快速的結果，進一步推動市場的增長。 近年來，輸血感染的預防和控制越來越受到重視。 這導致了嚴格的監管指南和質量保證計劃的出台，推動了先進輸血診斷的採用。 市場正在見證從傳統血清學方法向核酸檢測 (NAT) 和其他旨在提高靈敏度和特異性的分子技術的轉變。

血液和血液製品的需求不斷擴大

對血液和血液製品的需求不斷增長是輸血診斷市場的主要驅動力。 這種需求是由多種因素驅動的，包括手術、創傷和慢性病治療。 據世界衛生組織 (WHO) 統計，全世界每年估計有 1.125 億單位的血液捐獻。 隨著癌症和心血管疾病等在治療過程中通常需要輸血的疾病的患病率不斷增加，輸血需求預計將進一步增加。

提高對輸血感染的認識

人們對輸血感染 (TTI) 的認識和關注不斷增長，推動了對有效輸血診斷的需求。 TTI 是一種傳染病，可通過輸入受污染的血液或血液製品傳播。 醫療當局和血庫實施嚴格的監管指南和質量保證計劃，進一步提高了準確可靠診斷的重要性。 例如，美國疾病控制和預防中心 (CDC) 制定了獻血者篩查和檢測指南，以最大程度地降低 TTI 風險。 這種認識的提高導致了核酸檢測（NAT）等先進診斷方法的採用，這些方法能夠以更高的靈敏度和特異性檢測傳染源。

診斷技術的進步

診斷技術的進步對輸血診斷市場的增長做出了重大貢獻。 創新測試和系統的開發提供了更高的準確性、更快的結果和更高的自動化程度，徹底改變了輸血診斷領域。 例如，聚合□鍊式反應 (PCR) 和實時 PCR 等 NAT 技術的引入徹底改變了捐獻血液中傳染性病原體的檢測。 這些基於分子的方法具有高靈敏度和特異性，能夠及早檢測病原體，並降低輸血相關感染的風險。 此外，自動化和機器人技術的進步簡化了實驗室流程，從而提高了輸血診斷的通量和效率。 這些技術進步為醫療專業人員提供可靠、高效的工具來確保安全輸血，從而繼續推動市場向前發展。

監管挑戰和嚴格的合規要求

輸血診斷市場的主要限制因素之一是存在監管挑戰和嚴格的合規要求。 輸血過程有多項監管標準和指南，旨在確保血液製品的安全和質量。 這些法規的製定是為了最大限度地降低輸血相關感染和其他不良事件的風險。 然而，遵守這些法規可能很複雜，並且對醫療機構和血庫來說需要資源。 獲得監管部門批准、進行驗證研究以及遵守質量控制措施的過程可能非常耗時且成本高昂。 此外，監管標準的不斷更新和修訂也增加了行業參與者面臨的挑戰。 例如，在美國，血液製品設施受食品藥品監督管理局 (FDA) 監管，必須符合 FDA 的現行良好生產規範 (cGMP) 要求。 不遵守規定可能會導致處罰、聲譽受損，甚至停業。 此類監管挑戰和合規要求限制了市場增長，因為它們增加了開發和商業化的複雜性和成本。

按產品類別劃分，設備細分市場佔據主導地位

輸血診斷市場可按產品細分為試劑和試劑盒、設備和其他。 試劑和試劑盒用於各種檢測和化驗，如傳染病檢測、血型測定、相容性試驗等，在輸血診斷中發揮著重要作用。 這些產品的需求量很大，因為它們是消耗品，需要不斷補充。 由於獻血活動增加和輸血感染流行率上升等因素，預計 2023 年至 2031 年預測期內，試劑和試劑盒細分市場將以最高複合年增長率增長。 儀器，包括自動分析儀和實驗室儀器，對於執行診斷測試和獲得準確的結果至關重要。 這些儀器提高了效率、準確性和吞吐量，有助於其在輸血診斷中的高采用率。 因此，對先進診斷技術的需求和對高效實驗室流程的需求將使儀器儀表行業在 2022 年佔據收入的很大一部分。 其他部門包括用於輸血診斷的輔助產品和配件，例如控製材料、校準器和質量控制解決方案。 儘管該細分市場的市場份額相對較小，但它在支持整個輸血診斷過程中發揮著重要作用。

按應用劃分的血腥分類細分市場佔據主導地位

輸血診斷市場按應用分為血型和疾病篩查。 血型鑑定涉及確定個體的血型和 Rh 因子，以確保輸血期間供體與受體的相容性。 這是安全、成功輸血的重要步驟。 由於血型檢測是世界各地血庫、醫院和實驗室的常規檢測，因此到2022年，血型檢測領域將在市場中佔據很大的收入份額。 對血液和血液製品的需求不斷增長以及輸血程序數量的增加正在推動血型檢測領域的增長。 疾病篩查涉及檢測和診斷可通過輸血傳播的各種感染和疾病。 這包括愛滋病毒、肝炎、梅毒和瘧疾的疾病篩查。 疾病篩查對於預防傳染病傳播和保護捐獻者和受贈者的健康非常重要。 由於對血液安全的重視以及對傳染病檢測的嚴格規定的實施，預計疾病篩查領域在2023-2031年的預測期內將呈現高複合年增長率。

預測期內，北美將引領收入，亞太地區將引領增長

由於其完善的醫療基礎設施、高度的血液安全意識和嚴格的監管標準，北美在 2022 年市場收入中佔據很大份額。 該地區還受益於先進的醫療設施和廣泛的輸血服務。 由於輸血程序的增加、血液相關疾病患病率的增加以及先進診斷技術的日益採用，歐洲的市場份額僅次於北美。 由於中國和印度等國家患者數量增加、醫療基礎設施改善以及醫療成本上升等因素，預計亞太地區在 2023-2031 年預測期內將呈現最高的複合年增長率。 血液安全意識的提高以及輸血程序嚴格規定的實施也促進了該地區市場的增長。 由於改善醫療設施、提高獻血率和加強血液安全措施，拉丁美洲、中東和非洲地區的輸血診斷市場呈現穩定增長。

預測期內市場競爭將加劇

輸血診斷市場競爭非常激烈，幾家主要參與者都在努力增加其在市場上的影響力並獲得競爭優勢。 市場參與者包括 Bio-Rad Laboratories Inc.、Grifols、Immucor Inc.、Ortho Clinical Diagnostics、Quotient Limited、Beckman Coulter Inc.、F. Hoffmann-La Roche Ltd.、Abbott Laboratories、Becton、Dickinson and Company、Siemens Healthineers 等。 這些公司專注於各種戰略來維持其市場地位並推動增長。 輸血診斷市場公司採取的主要策略之一是產品開發和創新。 市場先驅大力投資於研發活動，以推出技術先進且可靠的診斷解決方案。 目的是提高輸血診斷的準確性、速度和效率，提高檢測能力，確保血液製品的安全。 合作、夥伴關係和收購是該市場上的公司採取的其他值得注意的策略。 通過戰略聯盟，公司旨在利用彼此的優勢，擴大其地理範圍並擴大其產品組合。 與血庫、醫院和研究機構的合作有助於企業建立強大的客戶群並進入更廣闊的市場。

內容

第 1 章前言

  • 報告內容
    • 報告的目的
    • 目標受眾
    • 主要產品
  • 市場細分
  • 調查方法

第 2 章執行摘要

第 3 章輸血診斷市場：競爭分析

  • 主要供應商的市場定位
  • 供應商採取的策略
  • 主要產業戰略
  • 層級分析：2022 年與 2031 年

第 4 章輸血診斷市場：宏觀分析和市場動態

  • 簡介
  • 2021-2031 年全球輸血診斷市場價值
  • 市場動態
    • 市場促進因素
    • 市場抑制因素
    • 主要問題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析

第 5 章輸血診斷市場：副產品 2021-2031

  • 市場概況
  • 增長和盈利分析：2022 年與 2031 年
  • 市場細分
    • 試劑和試劑盒
    • 設備
    • 其他

第 6 章輸血診斷市場：按應用分類 2021-2031

  • 市場概況
  • 增長和盈利分析：2022 年與 2031 年
  • 市場細分
    • 血型分類
    • 疾病篩查
    • 血清學疾病篩查
    • 分子疾病篩查

第 7 章輸血診斷市場：按最終用途 2021-2031

  • 市場概況
  • 增長和盈利分析：2022 年與 2031 年
  • 市場細分
    • 醫院
    • 血庫
    • 診斷實驗室
    • 其他

第 8 章北美輸血診斷市場 2021-2031

  • 市場概況
  • 輸血診斷市場：2021-2031 年（按產品）
  • 輸血診斷市場：按應用分類 2021-2031
  • 輸血診斷市場：按最終用途分類 2021-2031 年
  • 輸血診斷市場：2021-2031 年地區
    • 北美
      • 美國
      • 加拿大
      • 北美其他地區

第 9 章2021-2031 年英國和歐盟的輸血診斷市場

  • 市場概況
  • 輸血診斷市場：按產品2021-2031
  • 輸血診斷市場：按應用分類 2021-2031
  • 輸血診斷市場：按最終用途分類 2021-2031
  • 輸血診斷市場：按按產品2021-2031
    • 英國/歐盟
      • 英國
      • 德國
      • 西班牙
      • 意大利
      • 法國
      • 其他歐洲地區

第 10 章亞太輸血診斷市場 2021-2031

  • 市場概況
  • 輸血診斷市場：按產品2021-2031
  • 輸血診斷市場：按應用分類 2021-2031
  • 輸血診斷市場：按最終用途分類 2021-2031
  • 輸血診斷市場：按地區2021-2031
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 亞太地區其他地區

第 11 章拉丁美洲輸血診斷市場 2021-2031

  • 市場概況
  • 輸血診斷市場：按產品2021-2031
  • 輸血診斷市場：按應用分類 2021-2031
  • 輸血診斷市場：按最終用途分類 2021-2031
  • 輸血診斷市場：按地區2021-2031
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第 12 章 2021-2031 年中東和非洲輸血診斷市場

  • 市場概況
  • 輸血診斷市場：按產品2021-2031
  • 輸血診斷市場：按應用分類 2021-2031
  • 輸血診斷市場：按最終用途分類 2021-2031
  • 輸血診斷市場：按地區2021-2031
      • 中東和非洲
        • 海灣合作委員會
        • 非洲
        • 其他中東和非洲地區

    第 13 章公司簡介

    • Bio-Rad Laboratories Inc.
    • Grifols
    • Immucor Inc.
    • Ortho Clinical Diagnostics
    • Quotient Limited
    • Beckman Coulter Inc.
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Becton
    • Dickinson and Company
    • Siemens Healthineers
    • 其他特色公司
Product Code: 139607-06-23

The blood transfusion diagnostics market is a critical segment of the healthcare industry that plays a crucial role in ensuring safe and efficient blood transfusion practices. The market is expected to grow at a CAGR of 7% during the forecast period of 2023 to 2031. This market is driven by the increasing demand for blood and blood products, rising awareness about transfusion-transmitted infections, and the need for accurate and efficient diagnostic methods. The market revenue has been steadily growing, and it is expected to continue its upward trajectory in the coming years. The market's revenue is influenced by factors such as the increasing number of blood transfusions due to surgical procedures, trauma cases, and chronic diseases. Additionally, the rising prevalence of blood-related disorders and the growing geriatric population contribute to the demand for blood transfusion diagnostics. The advancements in technology have led to the development of innovative diagnostic methods that provide accurate and rapid results, further fuelling market growth. In recent years, there has been a growing emphasis on the prevention and control of transfusion-transmitted infections. This has led to the introduction of stringent regulatory guidelines and quality assurance programs, which drive the adoption of advanced blood transfusion diagnostics. The market is witnessing a shift from conventional serological methods to nucleic acid testing (NAT) and other molecular techniques for improved sensitivity and specificity.

Growing Demand for Blood and Blood Products

The increasing demand for blood and blood products is a major driver of the blood transfusion diagnostics market. This demand stems from various factors such as surgical procedures, trauma cases, and the treatment of chronic diseases. According to the World Health Organization (WHO), an estimated 112.5 million units of blood donations are collected globally each year. The demand for blood transfusions is expected to rise further due to the growing prevalence of diseases such as cancer and cardiovascular disorders, which often require blood transfusions during treatment.

Rising Awareness about Transfusion-Transmitted Infections

The awareness and concern regarding transfusion-transmitted infections (TTIs) have been on the rise, driving the need for effective blood transfusion diagnostics. TTIs are infections that can be transmitted through the transfusion of contaminated blood or blood products. The implementation of stringent regulatory guidelines and quality assurance programs by healthcare authorities and blood banks has further emphasized the importance of accurate and reliable diagnostics. For example, the Centers for Disease Control and Prevention (CDC) in the United States has established guidelines for the screening and testing of blood donors to minimize the risk of TTIs. This increased awareness has led to the adoption of advanced diagnostic methods, including nucleic acid testing (NAT), to detect infectious agents with higher sensitivity and specificity.

Advancements in Diagnostic Technologies

Advancements in diagnostic technologies have significantly contributed to the growth of the blood transfusion diagnostics market. The development of innovative tests and systems that offer improved accuracy, rapid results, and enhanced automation has transformed the field of blood transfusion diagnostics. For instance, the introduction of NAT techniques, such as polymerase chain reaction (PCR) and real-time PCR, has revolutionized the detection of infectious agents in donated blood. These molecular-based methods offer high sensitivity and specificity, enabling the early detection of pathogens and reducing the risk of transfusion-transmitted infections. Furthermore, advancements in automation and robotics have streamlined laboratory processes, allowing for higher throughput and efficiency in blood transfusion diagnostics. These technological advancements continue to drive the market forward by providing healthcare professionals with reliable and efficient tools for ensuring safe blood transfusions.

Regulatory Challenges and Stringent Compliance Requirements

One of the key restraints in the blood transfusion diagnostics market is the presence of regulatory challenges and stringent compliance requirements. The blood transfusion process involves several regulatory standards and guidelines aimed at ensuring the safety and quality of blood products. These regulations are implemented to minimize the risk of transfusion-transmitted infections and other adverse events. However, compliance with these regulations can be complex and resource-intensive for healthcare facilities and blood banks. The process of obtaining regulatory approvals, conducting validation studies, and adhering to quality control measures can be time-consuming and costly. Additionally, the constant updates and revisions to regulatory standards add to the challenges faced by industry players. For example, in the United States, blood establishments are regulated by the Food and Drug Administration (FDA) and must comply with the FDA's Current Good Manufacturing Practices (cGMP) requirements. Non-compliance can result in penalties, reputational damage, and even the suspension of operations. These regulatory challenges and compliance requirements pose a restraint on market growth, as they increase the complexity and cost of developing and commercializing blood transfusion diagnostics.

Instruments Segment Dominates the Market by Product Categories

The blood transfusion diagnostics market can be segmented based on products into reagents & kits, instruments, and others. Reagents & kits play a crucial role in blood transfusion diagnostics as they are used for various tests and assays to detect infectious agents, blood group typing, and compatibility testing. These products have a high demand due to their consumable nature and the need for continuous replenishment. The reagents & kits segment is expected to grow at the highest CAGR during the forecast period of 2023 to 2031, attributed to factors such as increasing blood donation activities and the rising prevalence of transfusion-transmitted infections. Instruments, including automated analyzers and laboratory equipment, are essential for performing diagnostic tests and ensuring accurate results. These instruments offer improved efficiency, precision, and throughput, contributing to their high adoption in blood transfusion diagnostics. The instruments segment, therefore, held a substantial share in terms of revenue in 2022, driven by the demand for advanced diagnostic technologies and the need for efficient laboratory processes. The "others" segment includes ancillary products and accessories used in blood transfusion diagnostics, such as control materials, calibrators, and quality control solutions. Although this segment may have a relatively smaller market share, it plays a vital role in supporting the overall blood transfusion diagnostics process.

Blood Grouping Segment Dominated the Market by Application

The blood transfusion diagnostics market can be categorized based on applications into blood grouping and disease screening. Blood grouping involves determining an individual's blood type and Rh factor to ensure compatibility between the donor and recipient during transfusions. It is an essential step in ensuring safe and successful blood transfusions. The blood grouping segment held a significant revenue share in the market in 2022 as it is a routine procedure performed in blood banks, hospitals, and laboratories worldwide. The increasing demand for blood and blood products, along with the rising number of transfusion procedures, drives the growth of the blood grouping segment. Disease screening involves the detection and diagnosis of various infectious diseases and conditions that can be transmitted through blood transfusions. This includes screening for diseases such as HIV, hepatitis, syphilis, and malaria, among others. Disease screening is critical to prevent the transmission of infections and safeguard the health of both the donor and recipient. The disease screening segment is expected to exhibit a higher CAGR during the forecast period of 2023 to 2031, due to the growing emphasis on blood safety and the implementation of stringent regulations regarding infectious disease testing.

North America to Lead Revenues, While APAC to Lead the Growth During the Forecast Period

North America held a significant share of revenues in the market in 2022 due to well-established healthcare infrastructure, high awareness about blood safety, and stringent regulatory standards. The region also benefits from advanced healthcare facilities and extensive blood transfusion services. Europe follows North America in terms of market share, driven by increasing blood transfusion procedures, rising prevalence of blood-related disorders, and growing adoption of advanced diagnostic technologies. The Asia Pacific region is expected to exhibit the highest CAGR during the forecast period of 2023 to 2031, due to factors such as a large patient population, improving healthcare infrastructure, and increasing healthcare expenditure in countries like China and India. Rising awareness about blood safety and the implementation of strict regulations for blood transfusion procedures also contribute to the market growth in this region. Latin America and the Middle East & Africa regions are witnessing steady growth in the blood transfusion diagnostics market, driven by improving healthcare facilities, increasing blood donation rates, and efforts to enhance blood safety measures.

Market Competition to Intensify During the Forecast Period

The blood transfusion diagnostics market is highly competitive, with several key players striving to enhance their market presence and gain a competitive edge. Prominent companies in the market include Bio-Rad Laboratories Inc., Grifols, Immucor Inc., Ortho Clinical Diagnostics, Quotient Limited, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, and Siemens Healthineers, among others. These players focus on various strategies to maintain their market position and drive growth. One of the key strategies adopted by companies in the blood transfusion diagnostics market is product development and innovation. Market players invest significantly in research and development activities to introduce technologically advanced and reliable diagnostic solutions. They aim to enhance the accuracy, speed, and efficiency of blood transfusion diagnostics, offering improved testing capabilities and ensuring the safety of blood products. Collaborations, partnerships, and acquisitions are other notable strategies employed by companies in this market. Through strategic alliances, companies aim to leverage each other's strengths, expand their geographic reach, and broaden their product portfolios. Collaborations with blood banks, hospitals, and research institutions help companies establish a strong customer base and gain access to a wider market.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Blood Transfusion Diagnostics market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Blood Transfusion Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Reagents & Kits
  • Instruments
  • Others

Application

  • Blood Grouping
  • Disease Screening
  • Serological Disease Screening
  • Molecular Disease Screening

End-use

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Blood Transfusion Diagnostics market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Blood Transfusion Diagnostics market?
  • Which is the largest regional market for Blood Transfusion Diagnostics market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Blood Transfusion Diagnostics market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Blood Transfusion Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Blood Transfusion Diagnostics Market
  • 2.2. Global Blood Transfusion Diagnostics Market, By Product, 2022 (US$ Million)
  • 2.3. Global Blood Transfusion Diagnostics Market, By Application, 2022 (US$ Million)
  • 2.4. Global Blood Transfusion Diagnostics Market, By End-use, 2022 (US$ Million)
  • 2.5. Global Blood Transfusion Diagnostics Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Blood Transfusion Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Blood Transfusion Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Blood Transfusion Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Blood Transfusion Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Blood Transfusion Diagnostics Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Reagents & Kits
    • 5.3.2. Instruments
    • 5.3.3. Others

6. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Blood Grouping
    • 6.3.2. Disease Screening
    • 6.3.3. Serological Disease Screening
    • 6.3.4. Molecular Disease Screening

7. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Blood Banks
    • 7.3.3. Diagnostic Laboratories
    • 7.3.4. Others

8. North America Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
  • 8.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 8.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  • 8.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

9. UK and European Union Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
  • 9.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 9.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  • 9.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.4.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.4.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.5.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.5.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.6.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.6.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

10. Asia Pacific Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
  • 10.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 10.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  • 10.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.4.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.4.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.5.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.5.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.6.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.6.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

11. Latin America Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
  • 11.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 11.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  • 11.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

12. Middle East and Africa Blood Transfusion Diagnostics Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
  • 12.3. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
  • 12.4. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
  • 12.5.Blood Transfusion Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.1.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.1.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.2.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.2.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Blood Transfusion Diagnostics Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.3.1. Blood Transfusion Diagnostics Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.3.1. Blood Transfusion Diagnostics Market: By End-use, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Bio-Rad Laboratories Inc.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Grifols
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Immucor Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Ortho Clinical Diagnostics
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Quotient Limited
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Beckman Coulter Inc.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. F. Hoffmann-La Roche Ltd.
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Abbott Laboratories
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Becton
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Dickinson and Company
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Siemens Healthineers
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. Other Notable Players
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 2 Global Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 3 Global Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 4 North America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 5 North America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 6 North America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 7 U.S. Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 8 U.S. Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 9 U.S. Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 10 Canada Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 11 Canada Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 12 Canada Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 19 UK Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 20 UK Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 21 UK Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 22 Germany Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 23 Germany Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 24 Germany Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 25 Spain Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 26 Spain Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 27 Spain Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 28 Italy Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 29 Italy Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 30 Italy Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 31 France Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 32 France Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 33 France Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 37 Asia Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 38 Asia Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 39 Asia Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 40 China Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 41 China Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 42 China Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 43 Japan Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 44 Japan Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 45 Japan Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 46 India Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 47 India Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 48 India Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 49 Australia Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 50 Australia Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 51 Australia Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 52 South Korea Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 53 South Korea Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 54 South Korea Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 55 Latin America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 56 Latin America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 57 Latin America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 58 Brazil Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 59 Brazil Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 60 Brazil Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 61 Mexico Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 62 Mexico Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 63 Mexico Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 70 GCC Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 71 GCC Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 72 GCC Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 73 Africa Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 74 Africa Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 75 Africa Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Blood Transfusion Diagnostics Market By Product, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Blood Transfusion Diagnostics Market By Application, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Blood Transfusion Diagnostics Market By End-use, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Blood Transfusion Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Blood Transfusion Diagnostics Market: Quality Assurance
  • FIG. 5 Global Blood Transfusion Diagnostics Market, By Product, 2022
  • FIG. 6 Global Blood Transfusion Diagnostics Market, By Application, 2022
  • FIG. 7 Global Blood Transfusion Diagnostics Market, By End-use, 2022
  • FIG. 8 Global Blood Transfusion Diagnostics Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Blood Transfusion Diagnostics Market, 2022
  • FIG. 10 Market Positioning of Key Blood Transfusion Diagnostics Market Players, 2022
  • FIG. 11 Global Blood Transfusion Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 12 Global Blood Transfusion Diagnostics Market, By Product, 2022 Vs 2031, %
  • FIG. 13 Global Blood Transfusion Diagnostics Market, By Application, 2022 Vs 2031, %
  • FIG. 14 Global Blood Transfusion Diagnostics Market, By End-use, 2022 Vs 2031, %
  • FIG. 15 U.S. Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 22 France Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 24 China Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 26 India Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Blood Transfusion Diagnostics Market (US$ Million), 2021 - 2031